Upstream Bio has sailed to a phase 2 win in sinusitis and plans to push its candidate forward against a competitive current. Investigators randomized 81 adults with chronic rhinosinusitis with nasal ...
BP (LSE:BP) is increasing its focus on U.S. shale output as a core part of its renewed emphasis on upstream oil and gas. The company is prioritising new upstream projects in the U.S. as it rebalances ...
– Verekitug provided statistically significant and clinically meaningful reductions in annualized asthma exacerbation rate (AAER) with 100 mg q12 and 400 mg q24 week dosing – – Verekitug also ...
New analyses of efficacy endpoints from the Phase 2 VIBRANT trial of verekitug in CRSwNP to be presented during the late-breaking poster session - ...
US EPC contractor KBR tells Upstream how Reliability, Availability, and Maintainability (RAM) analysis is helping operators minimise and mitigate downtime ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results